Thursday, February 14, 2019

US FDA News: FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices

FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices
Read more: FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices